Clinical characteristics | Cases (%) |
---|---|
Histological type | |
Endometrioid endometrial adenocarcinoma | 395(74.81%) |
Mixed serous and endometrioid | 22(4.17%) |
Serous endometrial adenocarcinoma | 111(21.02%) |
Histologic grade | |
G1 | 97(18.37%) |
G2+G3 | 431(81.63%) |
Clinical stage | |
I + II | 381(72.16%) |
III + IV | 147(27.84%) |
Age at initial pathologic diagnosis | |
< 60 | 174(32.95%) |
≥60 | 352(66.67%) |
NAa | 2(0.38%) |
Hypertension | |
YES | 260(49.24%) |
NO | 178(33.71%) |
NA | 90(17.05%) |
History of neo adjuvant treatment | |
YES | 2(0.38%) |
NO | 526(99.26%) |
Diabetes | |
YES | 108(20.45%) |
NO | 300(56.82%) |
NA | 120(22.73%) |